216 related articles for article (PubMed ID: 25088467)
61. Unusual cranial infection caused by Citrobacter Koseri.
Das S; Ross N
Br J Neurosurg; 2020 Feb; 34(1):94-95. PubMed ID: 29235359
[TBL] [Abstract][Full Text] [Related]
62. Sepsis, meningitis and cerebral abscesses caused by Citrobacter koseri.
Vaz Marecos C; Ferreira M; Ferreira MM; Barroso MR
BMJ Case Rep; 2012 Jan; 2012():. PubMed ID: 22665908
[TBL] [Abstract][Full Text] [Related]
63. Panophthalmitis secondary to infection with Citrobacter koseri.
Barsam A; Heatley CJ; Herbert L
Eye (Lond); 2006 Dec; 20(12):1468-70. PubMed ID: 16691260
[No Abstract] [Full Text] [Related]
64. CTX-M-35 extended-spectrum beta-lactamase conferring ceftazidime resistance in Citrobacter koseri.
Tian GB; Adams-Haduch JM; Qureshi ZA; Wang HN; Doi Y
Int J Antimicrob Agents; 2010 Apr; 35(4):412-3. PubMed ID: 20138478
[No Abstract] [Full Text] [Related]
65.
Kataoka H; Mori T; Into T
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33439115
[No Abstract] [Full Text] [Related]
66. Apparent transmission of Citrobacter koseri in catheterized residents on a 17-bed nursing home wing.
Drinka PJ; Gauerke C; Miller J; Stemper ME; Reed KD
J Am Geriatr Soc; 2003 Jan; 51(1):140-1. PubMed ID: 12534868
[No Abstract] [Full Text] [Related]
67. Agranulocytosis and citrobacter infection associated with jamu, a herbal remedy containing phenylbutazone.
Paul J; Duncan JR; Sharp P; Norris A; Siddiq MA; Bacon C; Weighill J
Clin Infect Dis; 2005 Jun; 40(12):1859-60. PubMed ID: 15909279
[No Abstract] [Full Text] [Related]
68. Resistance in gram-negative bacteria: enterobacteriaceae.
Paterson DL
Am J Med; 2006 Jun; 119(6 Suppl 1):S20-8; discussion S62-70. PubMed ID: 16735147
[TBL] [Abstract][Full Text] [Related]
69. Clinical characteristics of Citrobacter meningitis in adults: High incidence in patients with a postneurosurgical state and strains not susceptible to third-generation cephalosporins.
Lien CY; Lee JJ; Chien CC; Huang CR; Lu CH; Chang WN
J Clin Neurosci; 2018 Aug; 54():83-87. PubMed ID: 29907390
[TBL] [Abstract][Full Text] [Related]
70. Antibiotic sensitivity pattern of Citrobacter isolated from various clinical specimens in a tertiary care hospital.
Shetty J; Kotigadde S
Indian J Pathol Microbiol; 2007 Jul; 50(3):666-8. PubMed ID: 17883179
[TBL] [Abstract][Full Text] [Related]
71. [Spondylitis due to Citrobacter diversus. Case report and review of Citrobacter diversus infections].
Müllner GF; Keller H
Schweiz Med Wochenschr; 1992 Aug; 122(31-32):1173-7. PubMed ID: 1496345
[TBL] [Abstract][Full Text] [Related]
72. CkP1 bacteriophage, a S16-like myovirus that recognizes Citrobacter koseri lipopolysaccharide through its long tail fibers.
Oliveira H; Santos S; Pires DP; Boeckaerts D; Pinto G; Domingues R; Otero J; Briers Y; Lavigne R; Schmelcher M; Dötsch A; Azeredo J
Appl Microbiol Biotechnol; 2023 Jun; 107(11):3621-3636. PubMed ID: 37133800
[TBL] [Abstract][Full Text] [Related]
73. Multiple antibiotic resistance in Klebsiella spp. and other Enterobacteriaceae isolated in Singapore.
Inglis TJ; Kumarasinghe G; Chow C; Liew HY
Singapore Med J; 1994 Dec; 35(6):602-4. PubMed ID: 7761885
[TBL] [Abstract][Full Text] [Related]
74. Citrobacter koseri, an unusual exogenous endoftalmitis.
Ortega-Prades G; Pérez-Torregrosa VT; Carot-Sanmillán H; Cifre-Fabra Y; Ruíz-Del Río N; Duch-Samper AM
Arch Soc Esp Oftalmol (Engl Ed); 2024 Feb; 99(2):82-86. PubMed ID: 38211828
[TBL] [Abstract][Full Text] [Related]
75. Citrobacter koseri related abortion and fetal septicemia in cattle.
Hashiguchi M; Sugi S; Mizuno Y; Hoshinoo K; Kokuho T; Shibahara T
J Vet Med Sci; 2023 Oct; 85(10):1094-1098. PubMed ID: 37661420
[TBL] [Abstract][Full Text] [Related]
76. Severe asthma patient with secondary Citrobacter koseri abdominal infection: first case report and review of the literature.
Xian M; Ji X; Zhong M; Su D; Guan J; Chen R
Gut Pathog; 2023 Oct; 15(1):49. PubMed ID: 37880761
[TBL] [Abstract][Full Text] [Related]
77. Citrobacter koseri: an unusual cause of pyogenic liver abscess.
Gupta M; Sharma A; Singh R; Lehl SS
BMJ Case Rep; 2013 Mar; 2013():. PubMed ID: 23505286
[TBL] [Abstract][Full Text] [Related]
78.
Tinevez D; Knezevic NN
BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31352398
[TBL] [Abstract][Full Text] [Related]
79. Profile of microorganisms and antimicrobial resistance at a tertiary care referral burn centre in Iran: emergence of Citrobacter freundii as a common microorganism.
Khorasani G; Salehifar E; Eslami G
Burns; 2008 Nov; 34(7):947-52. PubMed ID: 18378087
[TBL] [Abstract][Full Text] [Related]
80. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
